Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) EBIAT (2016 - 2025)

Prestige Consumer Healthcare has reported EBIAT over the past 16 years, most recently at $46.7 million for Q4 2025.

  • For Q4 2025, EBIAT fell 23.49% year-over-year to $46.7 million; the TTM value through Dec 2025 reached $186.5 million, down 12.82%, while the annual FY2025 figure was $214.6 million, 2.52% up from the prior year.
  • EBIAT for Q4 2025 was $46.7 million at Prestige Consumer Healthcare, up from $42.2 million in the prior quarter.
  • Over five years, EBIAT peaked at $61.0 million in Q4 2024 and troughed at -$240.6 million in Q1 2023.
  • A 5-year average of $35.9 million and a median of $50.6 million in 2021 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: crashed 561.84% in 2023 and later soared 120.56% in 2024.
  • Year by year, EBIAT stood at $50.2 million in 2021, then grew by 3.46% to $52.0 million in 2022, then rose by 2.11% to $53.0 million in 2023, then rose by 15.05% to $61.0 million in 2024, then fell by 23.49% to $46.7 million in 2025.
  • Business Quant data shows EBIAT for PBH at $46.7 million in Q4 2025, $42.2 million in Q3 2025, and $47.5 million in Q2 2025.